
Regional Monitoring EECA
by ECUO PLWH

# | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Russian Federation | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 7.01 | 61920 | 120 | 841.2 | 516 | 434059.19 | 2016 | Yes | Yes | Not specified | |||
2 | Russian Federation | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 6.3308 | 36000 | 120 | 759.7 | 300 | 227910 | 2015 | Not specified | Not specified | Not specified | |||
3 | Republic of Latvia | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 6.1753 | 120 | 120 | 741.03 | 1 | 741.03 | 2015 | Not specified | Not specified | Not specified |